Researchers reviewed findings and clinical messages from the Women’s Health Initiative 30 years after launch
On May 1, 2024, researchers at the National Institutes of Health (NIH) announced a review in JAMA that…
On May 1, 2024, researchers at the National Institutes of Health (NIH) announced a review in JAMA that…
On Apr. 29, 2024, Oregon Health Sciences University (OHSU) reported a patient with the first documented case of…
On Apr. 26, 2024, engineers at Washington University in St. Louis announced a new imaging technique that give…
On Apr. 1, 2024, Otsuka Pharmaceutica and Click Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
On Mar. 21, 2024, Eledon Pharmaceuticals announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a…
On Mar. 1, 2024, researchers at the National Institutes of Health (NIH) announced they had identified antibodies targeting…
On Feb. 28, 2024, the CDC Advisory Committee on Immunization Practices’ (ACIP) announced a recommendation for adults ages…
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM) awarded $56 million to fund various clinical…
On Feb. 9, 2024, the state of Alaska Department of Health Alaska Department of Health confirmed the first…
On Jan. 16, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved CRISPR Therapeutics’ CASGEVY…
On Jan. 10, 2024, an National Institutes of Health (NIH) supported study announced an n atlas revealing the…
On Jan. 9, 2024, Biogen and Eisai announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody ‘LEQEMBI’…
On Dec. 14, 2023, Biogen and Sage Therapeutics announced ZURZUVAE (zuranolone) 50 mg (two 25 mg capsules per…
On Dec. 13, 2023, for the first time ever, an international team of researchers announced they had created…
On Dec. 8, 2023, bluebird bio announced the U.S. commercial launch of its LYFGENIA’ (lovotibeglogene autotemcel, also known…
On Dec. 5, 2023, Novavax announced that Health Canada had granted expanded authorization for Nuvaxovid XBB.1.5 Vaccine (Recombinant…
On Dec. 4 2023, the University of Wisconsin-Madison researchers announced that while analyzing data from wastewater samples collected…
On Nov. 29, 2023, Novavax’s partner, SK bioscience, announced that Novavax’s updated COVID-19 vaccine (NVX-CoV2601) had received Emergency…
On Nov. 10, 2023, surgeons in New York announced they had performed the first-ever whole-eye transplant in a…
On Oct. 30, 2023,California Department of Public Health reported The first locally acquired case of dengue in California…
On Oct. 18, 2023, Novavax announced that Singapore’s Health Sciences Authority (HSA) has granted full approval for Novavax’s…
On Oct. 3, 2023, Novavax announced that it’s COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) had received Emergency Use…
On Oct. 2, 2023, the Nobel Prize in Physiology or medicine was awarded jointly to Katalin Kariko and…
On Sept. 29, 2023, through the Future Manufacturing program, the U.S. National Science Foundation (NSF) announced targeted investments…
On Sept. 28, 2023, Pfizer and BioNTech that Health Canada had authorized the companies’ Omicron XBB.1.5-adapted monovalent COVID-19…
On Sept. 20, 2023, the National Institutes of Health announced that a trial of a preventive HIV vaccine…
On Sept. 14, 2023, the World Health Organization (WHO) reported that as of Sept. 11, 2023, a total…
On Sept. 12, 2023, the National Institutes of Health announced it was establishing the Multi-Omics for Health and…
COVID-19 Vacations Redux iIlustrates once again the pits and perils vacation travelers face as they begin their Summer…
On Aug. 25, 2023, Harvardメs Center for Brain Science announced the ceation of an eye atlas that pinpoints…